Literature DB >> 11588551

Esophageal dysmotility in an adult with chronic granulomatous disease.

M Golioto1, J B O'Connor.   

Abstract

Chronic granulomatous disease (CGD) is a group of hereditary disorders of impaired intracellular destruction of phagocytosed bacteria. Gastrointestinal manifestations are present, with hepatic abscess being the most common. In this case report, we present an adult with CGD with esophageal involvement, which has been described in only one other adult. The clinical history, modalities of diagnosis (including endoscopy, barium radiography, and esophageal manometry), and therapeutic strategies pertaining to the esophageal manifestations of CGD are discussed. A review of the pertinent available literature is provided.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588551     DOI: 10.1097/00004836-200110000-00016

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients.

Authors:  Meghna Alimchandani; Jin-Ping Lai; Phyu Phyu Aung; Sajneet Khangura; Natasha Kamal; John I Gallin; Steven M Holland; Harry L Malech; Theo Heller; Markku Miettinen; Martha M Quezado
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

2.  Gastrointestinal Features of Chronic Granulomatous Disease Found During Endoscopy.

Authors:  Sajneet K Khangura; Natasha Kamal; Nancy Ho; Martha Quezado; Xiongce Zhao; Beatriz Marciano; Jennifer Simpson; Christa Zerbe; Gulbu Uzel; Michael D Yao; Suk See DeRavin; Colleen Hadigan; Douglas B Kuhns; John I Gallin; Harry L Malech; Steven M Holland; Theo Heller
Journal:  Clin Gastroenterol Hepatol       Date:  2015-11-09       Impact factor: 11.382

3.  Twenty-year follow-up of esophageal involvement in chronic granulomatous disease.

Authors:  Heather L Laskey; Lakshmi Gopal; John I Gallin; Steven M Holland; Theo Heller
Journal:  Am J Gastroenterol       Date:  2009-09       Impact factor: 10.864

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.